BLTE

Conviction 27HealthcareScan · Fri, Jun 26, 2026

BLTE$149.03-0.53%

ResistanceSupportVol 14Insider sell

Vol MA14 216.1K

Mar 27Apr 15May 4May 20Jun 9Jun 26

BELITE BIO, INCBiotechnologywww.belitebio.com ↗

Price149.03

Change-0.53%

Gap+0.11%

Rel volume0.64×

Avg volume259.92K

Avg $ vol37.32M

SMA 20143.13

SMA 50149.39

SMA 200140.43

Price vs 50-0.24%

Price vs 200+6.12%

MA stackmixed

50/200 cross—

Supertrenddown · 159.79

RSI (14)54

MACD hist1.60

MACD cross—

Stoch %K / %D79 / 84

ADX (14)16

+DI / −DI17 / 12

RSI divergence—

MACD divergence—

ATR %+4.95%

ADR %5.54%

52w high190.30

52w low56.81

From 52w high-21.69%

Above 52w low+162.33%

New 52w highNo

SqueezeFired

Bollinger width13.41%

%B0.81

Donchian pos83.83%

Donchian high152.70

Donchian low130.00

AVWAP (52w high)159.97

vs AVWAP high-6.84%

AVWAP (52w low)143.92

vs AVWAP low+3.55%

OBV trendFlat

Chaikin MF (20)0.07

Today vs 20d0.64×

Avg vol (14d)216.1K

Avg vol (20d)259.92K

Avg $ vol (20d)37.32M

Market cap—

RS 3m (vs SPY)-15.16%

RS 6m (vs SPY)-10.86%

RS line new highNo

Trend template4/8

Technical rank50.5

1 week+1.99%

1 month+4.88%

3 months-0.10%

6 months-3.54%

1 year+143.91%

YTD-6.43%

P/E—

P/B7.67

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current50.02

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target216.20

Target upside43.98%

Analyst ratingBuy

Institutional22.83%

Ent. value5.55B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out40.09M

Employees41

ListedFri, Apr 29, 2022

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction27 / 100

Pattern quality—

Tech rank50.5 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance155.67

Support132.01

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in BLTE

All disclosures →

No recent disclosed trades by Congress in BLTE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BLTE · 10 sells

Insider	Side	Shares	Value	Traded	Filed
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-18	Sell	96	$14K	2026-06-18	2026-06-22
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-18	Sell	3.75K	$542K	2026-06-18	2026-06-22
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-18	Sell	4.86K	$707K	2026-06-18	2026-06-22
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-18	Sell	1.2K	$175K	2026-06-18	2026-06-22
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-18	Sell	96	$14K	2026-06-18	2026-06-22
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-16	Sell	3.14K	$438K	2026-06-16	2026-06-17
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-16	Sell	2.05K	$283K	2026-06-16	2026-06-17
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-16	Sell	784	$108K	2026-06-16	2026-06-17
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-16	Sell	540	$76K	2026-06-16	2026-06-17
Scholl Hendrik Peter Chief Medical Officer · American depositary share · 2026-06-16	Sell	100	$14K	2026-06-16	2026-06-17

SEC filings

EDGAR filings in BLTE · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.